Mohd Ashhad: Cryoprecipitate – A Small Blood Component with a Big Clinical Role
Mohd Ashhad, Assistant at Blood bank, shared a post on LinkedIn:
“Cryoprecipitate: A Small Blood Component with a Big Clinical Role
In transfusion medicine, every blood component has a specific purpose.
Cryoprecipitate is a plasma-derived blood component that plays an important role in managing certain bleeding conditions.
What is Cryoprecipitate?
Cryoprecipitate is prepared by thawing Fresh Frozen Plasma (FFP) at cold temperatures and collecting the precipitated proteins. It is then refrozen for storage.
What does Cryoprecipitate contain?
It is rich in:
- Fibrinogen (Factor I)
- Factor VIII
- von Willebrand Factor (vWF)
- Factor XIII
- Fibronectin
When is it used?
Cryoprecipitate may be transfused when there is significant hypofibrinogenemia or dysfibrinogenemia, particularly in situations such as:
- Massive hemorrhage
- Major trauma or surgery with low fibrinogen
- Disseminated Intravascular Coagulation (DIC) with bleeding
- Certain congenital fibrinogen disorders
Important point:
Cryoprecipitate should not be used simply as a source of Factor VIII or vWF when specific factor concentrates are available and appropriate.
Its use should be guided by clinical condition and laboratory results, especially fibrinogen levels.
From donor to patient, every component matters.
Proper preparation, storage, identification, compatibility procedures, and transfusion practices are essential for patient safety.
As laboratory professionals and blood bank technologists, understanding the preparation, contents, indications, and quality requirements of cryoprecipitate is an important part of transfusion medicine.”
Stay updated with Hemostasis Today.
-
Aug 6, 2026, 15:53Pall T. Onundarson: Frail Elderly Korean Atrial Fibrillation Patients Do Worse If Switched to DOACs in a Nationwide Observational Study
-
Aug 6, 2026, 15:46Zain Khalpey: Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation
-
Aug 6, 2026, 15:19Faris Otmani: New Systematic Review Evaluates TAVR and SAVR in Low-Risk Patients
-
Aug 6, 2026, 15:13How a PERT Team Navigates Severe Pregnancy PE – JTH
-
Aug 6, 2026, 15:05Melissa Hollo: Are All MS Symptoms Really Due to MS?
-
Aug 6, 2026, 15:03Zubair Naimullah: Early Recognition of Deep Vein Thrombosis Can Save Lives
-
Aug 6, 2026, 14:45Leonard Valentino: Why Hemophilic Arthropathy Is More Than an Inflammatory Joint Disease
-
Aug 6, 2026, 14:31Scarlet R. Spain: Early Recognition of Adolescent Cerebral Venous Thrombosis
-
Aug 6, 2026, 13:50Diagnostic Challenges of Pulmonary Embolism in Postpartum Patients – ISTH